Pfizer Launches Global Regenerative Medicine Research Unit
- Details
- Category: Pfizer

SEROQUEL XR and SEROQUEL Approved in Europe for New Indications
- Details
- Category: AstraZeneca

Tarceva brings new hope to patients with advanced non-small cell lung cancer
- Details
- Category: Roche

Bayer's Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome
- Details
- Category: Bayer

CRESTOR® is in line with other marketed statins - new data from the JUPITER study
- Details
- Category: AstraZeneca

Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
- Details
- Category: Genzyme

GlaxoSmithKline to acquire Genelabs Technologies to increase focus on novel small molecule therapies
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- AstraZeneca PLC Third Quarter and Nine Months Results 2008
- Novartis to acquire Nektar Therapeutics pulmonary business unit
- European CHMP adopts negative opinion on Cymbalta for the treatment of fibromyalgia
- Roche posts sustained double-digit sales growth for the first nine months of 2008
- Genzyme Reports Strong Third-Quarter Sales and Earnings Growth
- AstraZeneca Announces European SEROQUEL XR Submission
- Pfizer and UCB Announce Formation of New Company Cyclofluidic to Accelerate Drug Discovery Process